Rick A. Carpenter - 15 Aug 2026 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
18 Aug 2026, 16:27:16 UTC
Prior SEC filing
02 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jerilyn Laskie, Attorney-in-Fact for Rick A. Carpenter

Key filing fact

Rick A. Carpenter filed Form 4 for TANDEM DIABETES CARE INC (TNDM) on 18 Aug 2026.

Key facts

  • This page summarizes Rick A. Carpenter's Form 4 filing for TANDEM DIABETES CARE INC (TNDM).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 18 Aug 2026, 16:27.

Change

  • Previous filing in this sequence was filed on 02 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001513889 Primary reporting owner

Carpenter Rick

Relationship
EVP & Chief Technology Officer
Address
12400 HIGH BLUFF DRIVE, SAN DIEGO
Signature
/s/ Jerilyn Laskie, Attorney-in-Fact for Rick A. Carpenter
Signature date
18 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TNDM transaction

Common Stock

Options Exercise

Transaction value
Shares
+897
Change %
+2.9%
Price
$0.000000*
Shares after
31,815
Date
15 Aug 2026
Ownership
Direct
TNDM transaction

Common Stock

Tax liability

Transaction value
Shares
-457
Change %
-1.4%
Price
$22.72*
Shares after
31,358
Date
15 Aug 2026
Ownership
Direct
Footnotes
F1
TNDM transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,610
Change %
+5.1%
Price
$0.000000*
Shares after
32,968
Date
15 Aug 2026
Ownership
Direct
TNDM transaction

Common Stock

Tax liability

Transaction value
Shares
-820
Change %
-2.5%
Price
$22.72*
Shares after
32,148
Date
15 Aug 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TNDM transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares
-897
Change %
-25%
Price
$0.000000*
Shares after
2,692
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
897
Exercise price
Footnotes
F2, F3, F4
TNDM transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares
-1,610
Change %
-13%
Price
$0.000000*
Shares after
11,268
Date
15 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,610
Exercise price
Footnotes
F3, F5, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Shares withheld by the Issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs). No shares were sold.

Footnote F2

Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).

Footnote F3

Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

Footnote F4

One-third of the RSUs granted on May 23, 2024 vested on May 15, 2025, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.

Footnote F5

Awarded on May 30, 2025 pursuant to the 2023 Plan.

Footnote F6

One-third of the RSUs granted on May 30, 2025 vested on May 15, 2026, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .